These findings suggest that lifting the immune suppression with TGFβ-targeting agents like OT101 may be most beneficial to those HGG patients with a less compromised immune system and underscore the importance of restricting the use of dexamethasone to only those cases with symptomatic brain edema. Here, TGFB1 is linked to brain edema.